AAPL344.59+5.09 (+1.50%) ▲|ABBV283.11-5.97 (-2.07%) ▼|ABT98.83-3.63 (-3.54%) ▼|ACN240.08+0.96 (+0.40%) ▲|ADBE255.87-0.86 (-0.34%) ▼|AMAT411.29+6.31 (+1.56%) ▲|AMD550.08+15.34 (+2.87%) ▲|AMGN435.60-3.34 (-0.76%) ▼|AMT179.03-4.53 (-2.47%) ▼|AMZN262.64+0.01 (+0.00%) ▲|AVGO337.09+2.72 (+0.81%) ▲|AXP323.91+5.57 (+1.75%) ▲|BA191.62+1.15 (+0.60%) ▲|BAC51.01+0.37 (+0.72%) ▲|BKNG157.98-5.94 (-3.62%) ▼|BLK1,136.54+7.86 (+0.70%) ▲|BMY60.84-0.85 (-1.37%) ▼|BNY146.34+2.09 (+1.45%) ▲|BRK-B542.91+3.09 (+0.57%) ▲|C123.25+0.74 (+0.60%) ▲|CAT736.22+10.98 (+1.51%) ▲|CL93.68-0.86 (-0.91%) ▼|CMCSA21.87-0.50 (-2.21%) ▼|COF209.61+8.05 (+3.99%) ▲|COP145.84-0.12 (-0.08%) ▼|COST995.37+0.76 (+0.08%) ▲|CRM242.91+0.48 (+0.20%) ▲|CSCO106.85+0.14 (+0.13%) ▲|CVS94.29-0.46 (-0.49%) ▼|CVX226.33+0.62 (+0.27%) ▲|DE631.14-1.07 (-0.17%) ▼|DHR232.70+8.46 (+3.77%) ▲|DIS110.84-0.83 (-0.74%) ▼|DUK121.43+0.10 (+0.08%) ▲|EMR163.27+2.81 (+1.75%) ▲|FDX298.99+0.23 (+0.08%) ▲|GD346.42+1.98 (+0.57%) ▲|GE300.83+0.96 (+0.32%) ▲|GEV928.69+38.36 (+4.31%) ▲|GILD152.93-3.59 (-2.29%) ▼|GM75.75-1.34 (-1.74%) ▼|GOOG328.98-7.42 (-2.21%) ▼|GOOGL332.99-7.29 (-2.14%) ▼|GS899.26+14.45 (+1.63%) ▲|HD314.35-0.76 (-0.24%) ▼|HON213.59+0.27 (+0.13%) ▲|IBM244.06+2.14 (+0.88%) ▲|INTC92.55+0.86 (+0.93%) ▲|INTU334.65-0.64 (-0.19%) ▼|ISRG431.71-6.30 (-1.44%) ▼|JNJ255.95-3.42 (-1.32%) ▼|JPM333.71-1.55 (-0.46%) ▼|KO92.91-0.58 (-0.62%) ▼|LIN499.54-2.35 (-0.47%) ▼|LLY1,268.01-15.65 (-1.22%) ▼|LMT549.58+0.87 (+0.16%) ▲|LOW196.58-0.71 (-0.36%) ▼|LRCX266.80+3.35 (+1.27%) ▲|MA623.27+2.85 (+0.46%) ▲|MCD245.81-0.71 (-0.29%) ▼|MDLZ62.81-1.18 (-1.84%) ▼|MDT93.51-1.13 (-1.19%) ▼|META710.75+16.50 (+2.38%) ▲|MMM171.12-0.25 (-0.15%) ▼|MO73.94-0.70 (-0.94%) ▼|MRK148.69+0.39 (+0.26%) ▲|MS183.57+3.17 (+1.76%) ▲|MSFT531.69-0.18 (-0.03%) ▼|MU912.63+16.56 (+1.85%) ▲|NEE78.59-0.27 (-0.35%) ▼|NFLX65.26-3.43 (-4.99%) ▼|NKE37.49-0.39 (-1.03%) ▼|NOW153.29+3.75 (+2.51%) ▲|NVDA220.46+3.99 (+1.84%) ▲|ORCL130.08-1.06 (-0.81%) ▼|PEP135.12+1.10 (+0.82%) ▲|PFE29.77-0.34 (-1.13%) ▼|PG157.75-1.58 (-0.99%) ▼|PLTR199.53+6.93 (+3.60%) ▲|PM196.75-3.15 (-1.58%) ▼|QCOM178.26+2.55 (+1.45%) ▲|RTX191.12-2.22 (-1.15%) ▼|SBUX98.82-0.55 (-0.55%) ▼|SCHW91.92+1.03 (+1.13%) ▲|SO90.71+0.00 (+0.00%) ▲|SPG206.31-0.68 (-0.33%) ▼|T21.98-1.45 (-6.17%) ▼|TMO702.36+14.99 (+2.18%) ▲|TMUS153.32-4.44 (-2.81%) ▼|TSLA386.40+12.69 (+3.40%) ▲|TXN286.26+8.48 (+3.05%) ▲|UBER68.18-0.76 (-1.10%) ▼|UNH416.31-2.96 (-0.70%) ▼|UNP289.75+2.14 (+0.74%) ▲|UPS99.61+1.09 (+1.10%) ▲|USB59.31+0.22 (+0.36%) ▲|V409.27+2.70 (+0.66%) ▲|VZ43.41-1.14 (-2.55%) ▼|WFC82.43+0.23 (+0.28%) ▲|WMT118.01+0.16 (+0.13%) ▲|XOM177.68-0.18 (-0.10%) ▼|AAPL344.59+5.09 (+1.50%) ▲|ABBV283.11-5.97 (-2.07%) ▼|ABT98.83-3.63 (-3.54%) ▼|ACN240.08+0.96 (+0.40%) ▲|ADBE255.87-0.86 (-0.34%) ▼|AMAT411.29+6.31 (+1.56%) ▲|AMD550.08+15.34 (+2.87%) ▲|AMGN435.60-3.34 (-0.76%) ▼|AMT179.03-4.53 (-2.47%) ▼|AMZN262.64+0.01 (+0.00%) ▲|AVGO337.09+2.72 (+0.81%) ▲|AXP323.91+5.57 (+1.75%) ▲|BA191.62+1.15 (+0.60%) ▲|BAC51.01+0.37 (+0.72%) ▲|BKNG157.98-5.94 (-3.62%) ▼|BLK1,136.54+7.86 (+0.70%) ▲|BMY60.84-0.85 (-1.37%) ▼|BNY146.34+2.09 (+1.45%) ▲|BRK-B542.91+3.09 (+0.57%) ▲|C123.25+0.74 (+0.60%) ▲|CAT736.22+10.98 (+1.51%) ▲|CL93.68-0.86 (-0.91%) ▼|CMCSA21.87-0.50 (-2.21%) ▼|COF209.61+8.05 (+3.99%) ▲|COP145.84-0.12 (-0.08%) ▼|COST995.37+0.76 (+0.08%) ▲|CRM242.91+0.48 (+0.20%) ▲|CSCO106.85+0.14 (+0.13%) ▲|CVS94.29-0.46 (-0.49%) ▼|CVX226.33+0.62 (+0.27%) ▲|DE631.14-1.07 (-0.17%) ▼|DHR232.70+8.46 (+3.77%) ▲|DIS110.84-0.83 (-0.74%) ▼|DUK121.43+0.10 (+0.08%) ▲|EMR163.27+2.81 (+1.75%) ▲|FDX298.99+0.23 (+0.08%) ▲|GD346.42+1.98 (+0.57%) ▲|GE300.83+0.96 (+0.32%) ▲|GEV928.69+38.36 (+4.31%) ▲|GILD152.93-3.59 (-2.29%) ▼|GM75.75-1.34 (-1.74%) ▼|GOOG328.98-7.42 (-2.21%) ▼|GOOGL332.99-7.29 (-2.14%) ▼|GS899.26+14.45 (+1.63%) ▲|HD314.35-0.76 (-0.24%) ▼|HON213.59+0.27 (+0.13%) ▲|IBM244.06+2.14 (+0.88%) ▲|INTC92.55+0.86 (+0.93%) ▲|INTU334.65-0.64 (-0.19%) ▼|ISRG431.71-6.30 (-1.44%) ▼|JNJ255.95-3.42 (-1.32%) ▼|JPM333.71-1.55 (-0.46%) ▼|KO92.91-0.58 (-0.62%) ▼|LIN499.54-2.35 (-0.47%) ▼|LLY1,268.01-15.65 (-1.22%) ▼|LMT549.58+0.87 (+0.16%) ▲|LOW196.58-0.71 (-0.36%) ▼|LRCX266.80+3.35 (+1.27%) ▲|MA623.27+2.85 (+0.46%) ▲|MCD245.81-0.71 (-0.29%) ▼|MDLZ62.81-1.18 (-1.84%) ▼|MDT93.51-1.13 (-1.19%) ▼|META710.75+16.50 (+2.38%) ▲|MMM171.12-0.25 (-0.15%) ▼|MO73.94-0.70 (-0.94%) ▼|MRK148.69+0.39 (+0.26%) ▲|MS183.57+3.17 (+1.76%) ▲|MSFT531.69-0.18 (-0.03%) ▼|MU912.63+16.56 (+1.85%) ▲|NEE78.59-0.27 (-0.35%) ▼|NFLX65.26-3.43 (-4.99%) ▼|NKE37.49-0.39 (-1.03%) ▼|NOW153.29+3.75 (+2.51%) ▲|NVDA220.46+3.99 (+1.84%) ▲|ORCL130.08-1.06 (-0.81%) ▼|PEP135.12+1.10 (+0.82%) ▲|PFE29.77-0.34 (-1.13%) ▼|PG157.75-1.58 (-0.99%) ▼|PLTR199.53+6.93 (+3.60%) ▲|PM196.75-3.15 (-1.58%) ▼|QCOM178.26+2.55 (+1.45%) ▲|RTX191.12-2.22 (-1.15%) ▼|SBUX98.82-0.55 (-0.55%) ▼|SCHW91.92+1.03 (+1.13%) ▲|SO90.71+0.00 (+0.00%) ▲|SPG206.31-0.68 (-0.33%) ▼|T21.98-1.45 (-6.17%) ▼|TMO702.36+14.99 (+2.18%) ▲|TMUS153.32-4.44 (-2.81%) ▼|TSLA386.40+12.69 (+3.40%) ▲|TXN286.26+8.48 (+3.05%) ▲|UBER68.18-0.76 (-1.10%) ▼|UNH416.31-2.96 (-0.70%) ▼|UNP289.75+2.14 (+0.74%) ▲|UPS99.61+1.09 (+1.10%) ▲|USB59.31+0.22 (+0.36%) ▲|V409.27+2.70 (+0.66%) ▲|VZ43.41-1.14 (-2.55%) ▼|WFC82.43+0.23 (+0.28%) ▲|WMT118.01+0.16 (+0.13%) ▲|XOM177.68-0.18 (-0.10%) ▼|
14.6 C
New York
Wednesday, October 21, 2026

Tag: advisory

newsFORsourcecompanycontentinformation1releasesmarket

Cell Therapy Market to Reach USD 29.5 Billion by 2032, Growing at 21.5% CAGR | SkyQuest Technology Consulting

The cell therapy market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing demand for novel treatments,...

Cell Therapy Market to Reach USD 29.5 Billion by 2032, Growing at 21.5% CAGR | SkyQuest Technology Consulting

The cell therapy market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing demand for novel treatments,...

Former AdventHealth President & CEO Terry Shaw Joins RAAPID Advisory Board

LOUISVILLE, Ky., July 29, 2025 /PRNewswire/ -- RAAPID, a M12 (Microsoft Venture Fund) backed company and leading AI-powered risk adjustment solutions provider, today announced the...

Trust Emerges as Main Barrier to Agentic AI Adoption in Finance and Accounting, Despite Optimism Around the Tech

NEW YORK, July 29, 2025 /PRNewswire/ -- Artificial intelligence (AI) is projected to become a mainstream finance and accounting tool, according to a recent...

Giants Protocol Powers Tokenization of Real Estate for The Assembly Place, Backed by Singapore’s Sovereign Wealth Fund

SINGAPORE, July 29, 2025 (GLOBE NEWSWIRE) -- Giants Protocol, a pioneer in AI-powered real-world asset (RWA) tokenization, has announced a landmark collaboration with Singapore-based co-living operator The Assembly Place (TAP) to tokenize real estate assets. This strategic move showcases the protocol’s ability to transform physical infrastructure into on-chain, yield-generating opportunities. The announcement marks a key milestone in Giants’ journey, having been backed by Singapore’s Sovereign Wealth Fund since inception and now delivering tangible use cases in Asia’s fast-evolving tokenization landscape.

Amundi: First half and second quarter 2025 results

Amundi: First half and second quarter 2025 results

Questerre announces definitive agreement to acquire 100% of PX Energy

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS

FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

WALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and older, to reduce proteinuria. C3G and primary IC-MPGN are rare kidney diseases, affecting 5,000 people in the United States.1

New ETC report demonstrates that wind and solar-dominant power systems are competitive, reliable, and technically and economically feasible

LONDON, July 29, 2025 /PRNewswire/ -- The Energy Transitions Commission (ETC) has today published a landmark report, Power Systems Transformation: Delivering Competitive, Resilient Electricity...

New ETC report demonstrates that wind and solar-dominant power systems are competitive, reliable, and technically and economically feasible

LONDON, July 29, 2025 /PRNewswire/ -- The Energy Transitions Commission (ETC) has today published a landmark report, Power Systems Transformation: Delivering Competitive, Resilient Electricity...

EQT and CPP Investments to acquire NEOGOV, a provider of HR and compliance software for U.S. public sector agencies, from Warburg Pincus and Carlyle

The EQT X fund ("EQT") and Canada Pension Plan Investment Board ("CPP Investments") have agreed to acquire NEOGOV, which serves over 10,000 public sector agencies...

EQT and CPP Investments to acquire NEOGOV, a provider of HR and compliance software for U.S. public sector agencies, from Warburg Pincus and Carlyle

The EQT X fund ("EQT") and Canada Pension Plan Investment Board ("CPP Investments") have agreed to acquire NEOGOV, which serves over 10,000 public sector agencies...

iCRYO Adds Dr. Jason Sonners to Medical Advisory Board, Strengthens Commitment to Safe, Effective Hyperbaric Oxygen Therapy

HOUSTON, July 28, 2025 /PRNewswire/ -- iCRYO, a leading health, wellness, and longevity franchise, is proud to announce the appointment of Dr. Jason Sonners,...

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, July 28, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAdvisory

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers